Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Hepatitis Eradication Receiving Protease Inhibitor Administration

NCT03886077 is registered in ClinicalTrials.gov with Sentara Norfolk General Hospital as lead sponsor.

NCT NCT03886077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03886077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Hepatitis Eradication Receiving Protease Inhibitor Administration
Lead sponsor
Sentara Norfolk General Hospital
Phase
Observational
Overall status
Completed
Start date
March 20, 2019
Completion date
December 31, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, morality